Mitochondrial Trifunctional Protein Deficiency: Clinical Trials

3 trials for Mitochondrial Trifunctional Protein Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 no longer available, 1 terminated. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Terminated 1

Follow Mitochondrial Trifunctional Protein Deficiency: new trials by email Literature Review of Mitochondrial Trifunctional Protein Deficiency trials Research Report on Mitochondrial Trifunctional Protein Deficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Check: Expanded Screening in Newborns
Confirmatory Testing - Spinal Muscular Atrophy, Fragile X Syndrome
Active not recruitingRTI International300002018-10-152026-07-01
Vitamin E Treatment for Long-Chain 3-Hydroxyacyl Coenzyme A (CoA) Dehydrogenase (LCHAD) Associated Neuropathy
Vitamin E supplement - Peripheral Neuropathy, Mitochondrial Trifunctional Protein Deficiency
Not applicableTerminatedOregon Health and Science University12010-07-012015-10-21
Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism
triheptanoin - Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency, Carnitine Palmitoyltransferase Deficiencies (CPT1, CPT2)
No longer availableJerry Vockley, MD, PhD2021-12-10

Narrower conditions

Trifunctional Protein Deficiency With Myopathy And Neuropathy (3)  ·  Barth Syndrome (2)  ·  VLCAD deficiency (2)  ·  3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (1)  ·  3-Hydroxyacyl-CoA Dehydrogenase Deficiency (1)  ·  3-methylcrotonyl CoA carboxylase 1 deficiency (1)  ·  3-methylcrotonyl CoA carboxylase 2 deficiency (1)  ·  Acidemia, isovaleric (1)  ·  Acrodermatitis enteropathica (1)  ·  Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of (1)  ·  Adenine phosphoribosyltransferase deficiency (1)  ·  Adrenal hyperplasia, congenital, type 5 (1)  ·  Adrenocorticotropic hormone deficiency (1)  ·  Amaurosis congenita of Leber, type 2 (1)  ·  Anemia, Sickle Cell (1)

Broader conditions

Nervous System Diseases (3)  ·  Abnormalities, Multiple (2)  ·  Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Carbohydrate Metabolism, Inborn Errors (2)  ·  Cardiovascular Abnormalities (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Genetic Diseases, X-Linked (2)  ·  Heart Defects, Congenital (2)  ·  Heart Diseases (2)

Interventions

alpha-Tocopherol (1)  ·  triheptanoin (1)

Sponsors

Jerry Vockley, MD, PhD (1)  ·  Oregon Health and Science University (1)  ·  RTI International (1)

Countries

United States (3)

Top investigators

Curt Scharfe, MD, PhD (1)  ·  Jerry Vockley, MD, PhD (1)  ·  Melanie Gillingham, Ph.D (1)

Results publications

PMID 31315600, PMID 35142618

NIH funding

F32DK065400 (1)